Toronto Dominion Bank
EPRX

Toronto Dominion Bank’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Toronto Dominion Bank’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Sell
30,920
-1,978
-6% -$13.6K ﹤0.01% 1674
2026
Q1 		$237K Buy
+32,898
New +$265K ﹤0.01% 1551
2024
Q3 		– Sell
-118
Closed -$304 – 1467
2024
Q2 		$304 Buy
+118
New +$328 ﹤0.01% 1291

Other funds holding EPRX

BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Toronto Dominion Bank's EPRX Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Eupraxia Pharmaceuticals (EPRX) stake by 6% in Q2 2026, selling an estimated $13.6K and leaving 30,920 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

Toronto Dominion Bank first reported a position in EPRX in Q2 2024 and has held it in 3 quarters since. The position peaked at $237K in Q1 2026. 67 funds tracked by Wall St. Rank hold EPRX as of Q2 2026.

  • Toronto Dominion Bank held 30,920 shares of Eupraxia Pharmaceuticals worth $203K as of Q2 2026.
  • Toronto Dominion Bank sold 1,978 Eupraxia Pharmaceuticals shares in Q2 2026, an estimated $13.6K.
  • Eupraxia Pharmaceuticals made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1674 holding.
  • Toronto Dominion Bank first reported a position in Eupraxia Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
  • Toronto Dominion Bank's Eupraxia Pharmaceuticals position peaked at $237K in Q1 2026.
  • 67 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.